PL431521A1 - Kompozycja wspomagająca mineralizację zębów w postaci tabletki pudrowej - Google Patents
Kompozycja wspomagająca mineralizację zębów w postaci tabletki pudrowejInfo
- Publication number
- PL431521A1 PL431521A1 PL431521A PL43152119A PL431521A1 PL 431521 A1 PL431521 A1 PL 431521A1 PL 431521 A PL431521 A PL 431521A PL 43152119 A PL43152119 A PL 43152119A PL 431521 A1 PL431521 A1 PL 431521A1
- Authority
- PL
- Poland
- Prior art keywords
- mineralization
- teeth
- powder tablet
- vitamin
- composition supporting
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000033558 biomineral tissue development Effects 0.000 title abstract 2
- 239000000843 powder Substances 0.000 title abstract 2
- 244000299461 Theobroma cacao Species 0.000 abstract 2
- 235000009470 Theobroma cacao Nutrition 0.000 abstract 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 2
- 229930003316 Vitamin D Natural products 0.000 abstract 1
- 229930003448 Vitamin K Natural products 0.000 abstract 1
- PFRQBZFETXBLTP-UHFFFAOYSA-N Vitamin K2 Natural products C1=CC=C2C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-UHFFFAOYSA-N 0.000 abstract 1
- DKHGMERMDICWDU-GHDNBGIDSA-N menaquinone-4 Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 DKHGMERMDICWDU-GHDNBGIDSA-N 0.000 abstract 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 abstract 1
- 150000005846 sugar alcohols Chemical class 0.000 abstract 1
- 235000019166 vitamin D Nutrition 0.000 abstract 1
- 239000011710 vitamin D Substances 0.000 abstract 1
- 150000003710 vitamin D derivatives Chemical class 0.000 abstract 1
- 235000005282 vitamin D3 Nutrition 0.000 abstract 1
- 239000011647 vitamin D3 Substances 0.000 abstract 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 abstract 1
- 235000019168 vitamin K Nutrition 0.000 abstract 1
- 239000011712 vitamin K Substances 0.000 abstract 1
- 150000003721 vitamin K derivatives Chemical class 0.000 abstract 1
- 235000019143 vitamin K2 Nutrition 0.000 abstract 1
- 239000011728 vitamin K2 Substances 0.000 abstract 1
- 229940046008 vitamin d Drugs 0.000 abstract 1
- 229940021056 vitamin d3 Drugs 0.000 abstract 1
- 229940046010 vitamin k Drugs 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Przedmiotem wynalazku jest kompozycja wspomagająca mineralizację zębów w postaci tabletki pudrowej zawierającej witaminę K, witaminę D, kakao oraz co najmniej jedną farmaceutycznie dopuszczalną zaróbkę, charakteryzująca się tym, że zawiera witaminę K2 w ilości od 0,12% wag. do 0,45% wag., witaminę D3 w ilości od 0,04% wag. do 0,4% wag., natomiast kakao występuje w ilości od 6% do 15% wag. kompozycji, a co najmniej jedna farmaceutycznie dopuszczalna zaróbka zawiera co najmniej jeden alkohol cukrowy.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL431521A PL240840B1 (pl) | 2019-10-18 | 2019-10-18 | Kompozycja w postaci tabletki pudrowej |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL431521A PL240840B1 (pl) | 2019-10-18 | 2019-10-18 | Kompozycja w postaci tabletki pudrowej |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL431521A1 true PL431521A1 (pl) | 2021-04-19 |
| PL240840B1 PL240840B1 (pl) | 2022-06-13 |
Family
ID=75469930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL431521A PL240840B1 (pl) | 2019-10-18 | 2019-10-18 | Kompozycja w postaci tabletki pudrowej |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL240840B1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023207843A1 (en) * | 2022-01-13 | 2024-08-15 | Ids Research Societa' A Responsabilita' Limitata | Teeth whitening composition with vitamins |
-
2019
- 2019-10-18 PL PL431521A patent/PL240840B1/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL240840B1 (pl) | 2022-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020550341A1 (en) | Niraparib formulations | |
| MX2009007784A (es) | Composiciones de tiacumicinas estables. | |
| AU2018231044A8 (en) | Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol | |
| PH12020550815A1 (en) | Delayed release deferiprone tablets and methods of using the same | |
| PH12017502325B1 (en) | Orodispersible dosage unit containing an estetrol component | |
| MX2018011991A (es) | Composiciones para el cuidado bucal con una exhibicion de saborizante eficaz. | |
| EA202090029A1 (ru) | Твердая композиция карипразина для орального введения | |
| WO2019203771A3 (en) | Solid oral pharmaceutical compositions comprising sitagliptin | |
| PH12019500154A1 (en) | Formulation having improved ph-dependent drug-release characteristics, containing esomeprazole or pharmaceutically acceptable salt thereof | |
| PH12021550237A1 (en) | Bioavailable oral dosage forms. | |
| MY208261A (en) | Oral pharmaceutical composition | |
| MX2010004556A (es) | Formulacion farmaceutica de acido clavulanico. | |
| MX2020012280A (es) | Tableta oral para la generacion de saliva inducida. | |
| PL431521A1 (pl) | Kompozycja wspomagająca mineralizację zębów w postaci tabletki pudrowej | |
| MX2020008063A (es) | Nuevos usos. | |
| EA201991286A1 (ru) | Твердая фармацевтическая композиция для перорального применения, содержащая тенофовир и эмтрицитабин | |
| WO2020005189A3 (en) | Solid oral pharmaceutical compositions comprising teriflunomide | |
| PH12018000227B1 (en) | A pharmaceutical composition for improving or preventing progression of chronic kidney disease | |
| EA201892842A1 (ru) | Фармацевтические композиции, включающие сафинамид | |
| PH12020500045A1 (en) | Novel composition of enzalutamide oral dosage form and method of manufacturing thereof | |
| EP4537846A3 (en) | Anavex2-73 for the treatment of alzheimer s disease | |
| ZA202104617B (en) | Pharmaceutical compound, the method of its making and use as medicinal agent | |
| WO2020032883A3 (en) | Synergistic effects of a novel ketoprofen formulation including a gastro protective agent | |
| PL425832A1 (pl) | Genisteina oraz jej kompozycja do zastosowania w leczeniu choroby Alzheimera | |
| GEAP202416572A (en) | Oral dosage forms |